Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The Chan Zuckerberg Initiative has joined Scale Bio's '100 Million Cell Challenge' to accelerate single-cell genomics research. The initiative will fully subsidize support for 50 million cells, providing game-changing support and expanding possibilities for groundbreaking single-cell research. Participants are encouraged to submit large-scale single-cell project proposals, with all data being made available on CellxGene Discover. Additionally, GC Therapeutics has launched to scale and unlock the next generation of cell therapy, focusing on creating stem cell-based medicines for treating gastrointestinal, immunological, and neurological diseases. The company emerged from stealth and announced its Series A raise, with George Church playing a key role in the venture and using his own skin cells.
A new #celltherapy company takes its vision from four founders, and its skin from GC (George Church) https://t.co/aPqPCesQho via @statnews #IPSC #transcriptionfactors @GCTherapeutics "envisions turning induced pluripotent #stemcells into cells found in the nervous, immune, and…
Exciting times for the iPSC industry! A new report predicts major growth through 2030, with applications in #therapy, drug discovery, and personalized medicine. At Somite, we’re leading this revolution with cutting-edge tech. Read more: https://t.co/L2vB2ef9Fn @BusinessWire #AI https://t.co/fU9HFEr52D
Today at @pearvc, we are excited that @GCTherapeutics emerged from stealth to announce its Series A raise. @eddie_eltoukhy @Harvard @geochurch @wyssinstitute https://t.co/SaPuLrtOOE